Jan Pinkas insider trades

Open-market stock purchases and sales by Jan Pinkas, Chief Scientific Officer at Crescent Biopharma, Inc, from SEC Form 4 filings since Jul 16, 2025.

Recent trades

DateStockTradeValue
Jun 22, 2026CBIO Crescent Biopharma, IncSold$23.2K
Dec 15, 2025CBIO Crescent Biopharma, IncBought (not open market)—
Dec 15, 2025CBIO Crescent Biopharma, IncBought (not open market)—
Dec 15, 2025CBIO Crescent Biopharma, IncBought (not open market)—

Companies traded

  • CBIO Crescent Biopharma, Inc: 1 sale, last Jun 22, 2026

Get free alerts when Jan Pinkas files a new trade →